These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 31201054)

  • 21. Propagation of Brazilian Zika virus strains in static and suspension cultures using Vero and BHK cells.
    Nikolay A; Castilho LR; Reichl U; Genzel Y
    Vaccine; 2018 May; 36(22):3140-3145. PubMed ID: 28343780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation and production of a blood-free and chemically defined virus production media for VERO cells.
    Alfano R; Pennybaker A; Halfmann P; Huang CY
    Biotechnol Bioeng; 2020 Nov; 117(11):3277-3285. PubMed ID: 32648943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1.
    Gränicher G; Coronel J; Pralow A; Marichal-Gallardo P; Wolff M; Rapp E; Karlas A; Sandig V; Genzel Y; Reichl U
    Vaccine; 2019 Nov; 37(47):7019-7028. PubMed ID: 31005427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of yellow fever virus in microcarrier-based Vero cell cultures.
    Souza MC; Freire MS; Schulze EA; Gaspar LP; Castilho LR
    Vaccine; 2009 Oct; 27(46):6420-3. PubMed ID: 19559120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of an animal-component free medium for vero cells culture.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Biotechnol Prog; 2009; 25(6):1752-61. PubMed ID: 19768803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation.
    Genzel Y; Dietzsch C; Rapp E; Schwarzer J; Reichl U
    Appl Microbiol Biotechnol; 2010 Sep; 88(2):461-75. PubMed ID: 20617311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application prospects of the 2BS cell-adapted China fixed rabies virus vaccine strain 2aG4-B40.
    Xu Y; Weng L; Wang X; Li M; Guo W; Liu Y; Li X; Wang Z; Liu X; Xu S; He F; Hou Q; Li T; Du W; Zhang Y; Chang S; Zhang L; Zhang Y
    Virol J; 2024 Jul; 21(1):154. PubMed ID: 38978059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rabies virus production in high vero cell density cultures on macroporous microcarriers.
    Yokomizo AY; Antoniazzi MM; Galdino PL; Azambuja N; Jorge SA; Pereira CA
    Biotechnol Bioeng; 2004 Mar; 85(5):506-15. PubMed ID: 14760691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel process for production of hepatitis A virus in Vero cells grown on microcarriers in bioreactor.
    Sun MB; Jiang YJ; Li WD; Li PZ; Li GL; Jiang SD; Liao GY
    World J Gastroenterol; 2004 Sep; 10(17):2571-3. PubMed ID: 15300909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on the manufacture and immunogenicity of purified rabies vaccines on humans Vero cell].
    Yu W; Liu Z; Qian H; Lu H; Wang H; Li F; Dou Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb; 22(1):17-9. PubMed ID: 11860837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biological characteristics of the adapted rabies virus 3aG-V in Vero cell].
    Shi XS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):348-50. PubMed ID: 15650786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a measles vaccine production process in MRC-5 cells grown on Cytodex1 microcarriers and in a stirred bioreactor.
    Trabelsi K; Majoul S; Rourou S; Kallel H
    Appl Microbiol Biotechnol; 2012 Feb; 93(3):1031-40. PubMed ID: 21935589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon Inhibition Enhances the Pilot-Scale Production of Rabies Virus in Human Diploid MRC-5 Cells.
    Yang X; Wan M; Cai L; Hou A; Sun B; Zhou Y; Gao F; Su W; Jiang C
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
    Genzel Y; Fischer M; Reichl U
    Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: use of various cell lines.
    Merten OW; Kierulff JV; Castignolles N; Perrin P
    Cytotechnology; 1994; 14(1):47-59. PubMed ID: 7765112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of reovirus type-1 and type-3 from Vero cells grown on solid and macroporous microcarriers.
    Berry JM; Barnabé N; Coombs KM; Butler M
    Biotechnol Bioeng; 1999 Jan; 62(1):12-9. PubMed ID: 10099508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vero cells gain renal tubule markers in low-calcium and magnesium chemically defined media.
    Logan M; Rinas K; McConkey B; Aucoin MG
    Sci Rep; 2022 Apr; 12(1):6180. PubMed ID: 35418617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of human rabies vaccine in VERO cell culture using a microcarrier system.
    Mendonça RZ; Ioshimoto LM; Mendonça RM; De-Franco M; Valentini EJ; Beçak W; Raw I; Pereira CA
    Braz J Med Biol Res; 1993 Dec; 26(12):1305-17. PubMed ID: 8136732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of an HSV-1 production process involving serum-reduced culturing and bead-to-bead transfer.
    Wang H; Hu X; Zhang M; Yang L; Xu Y; Gu X; Jiang J; Hu W
    Appl Microbiol Biotechnol; 2024 Jun; 108(1):383. PubMed ID: 38896301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza viruses production: Evaluation of a novel avian cell line DuckCelt®-T17.
    Petiot E; Proust A; Traversier A; Durous L; Dappozze F; Gras M; Guillard C; Balloul JM; Rosa-Calatrava M
    Vaccine; 2018 May; 36(22):3101-3111. PubMed ID: 28571695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.